BioMedical Imaging Laboratory

Home

• A randomized, double-blind, multicenter study to evaluate the tolerability and effectiveness of etoricoxib 90 mg q.d. versus diclofenac sodium 75 mg b.i.d. in patients with rheumatoid arthritis

• A randomized, double-blind, placebo-controlled, multicenter, parallel-group study of one-year duration followed by 2 years of open-label treatment to determine the safety and efficacy of orally administered 2.5 mg or 5.0 mg risedronate in children > 4 to < 16 years old with osteogenesis imperfecta

Updated 29 March 2005